Alvotech is a privately owned, fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high quality biosimilar products. We are specialists in biogeneric product creation, all along the value chain from cell line development to commercial manufacturing. Our common goal: to be a global leader in the biosimilar space and to deliver high quality cost competitive products to patients worldwide.

We come from all around the world, bringing literally thousands of years of combined knowledge and expertise to our mission.

mAbs in pipeline


CEO message

Alvotech was founded in 2013, with the mission to create a specialty biogeneric’s company focused solely on fully integrated biosimilar product development and manufacturing for global markets.

Learn more